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CHILD-DRIVEN DESIGN OF MILK MICELLES 
FOR DRUG DELIVERY 
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RESULTS AND DISCUSSION 
INTRODUCTION 
Children differ from adults in many pharmacotherapeutic aspects [1] which have driven the design of paediatric drugs. In this 
respect, features, such as, ease and safety of administration, dose uniformity and flexibility, palatability, safety of excipients, 
stability and therapeutic equivalency of paediatric dosage forms [2]. While encapsulation has shown great potential regarding the 
development of innovative and improved drug products, milk is considered as a promising platform for paediatric drug delivery [3].  
In the present work, milk protein micelles incorporating model drugs, relevant in child treatment (paracetamol and vitamin A), 
have been produced and evaluated as drug delivery vehicles. The ability of chemical crosslinking of milk micelles to improve its 
thermodynamic stability and tailor drug release was also assessed. 
CONCLUSION 
Micelles produced from fresh milk proteins are promising prolonged-release carriers for drug delivery in paediatrics, which are also expected to be safe, 
provided the crosslinking reaction is controlled to minimize intra- and intermolecular crosslinking.  
Experiments are under way to ascertain if the use of fat milk would promote encapsulation of hydrophobic drugs. 
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MICELLES 
EXCIPIENTS 
MILK 
SDS-PAGE DENSITOMETRY 
Fig. 1 – Coomassie blue SDS-PAGE of skimmed 
milk protein extracts 
   1) Control; 2) F0; 3) F1; 4) F2; 5) F3; 6) F4; 7) F5 
Samples CN:drug ratio 
  
Vitamin A 
  
Paracetamol 
Casein (%) β-LG (%) Casein (%) β-LG (%) 
F0 0:3 80.82 19.18 87.48 12.52 
F1 0.09:3 89.94 10.06 87.65 12.35 
F2 0.18:3 89.16 10.84 85.72 14.28 
F3 0.51:3 86.48 13.52 84.63 15.37 
F4 0.63:3 82.76 17.24 90.93 9.07 
F5 1:3 90.14 9.86 88.72 11.28 
Table 1 – Percentage of casein (CN) and whey proteins (β-Lactoglobulin) 
assessed by densitometry of SDS-PAGE bands 
 
• Casein represents 81-91% of the proteins' total mass and -lactoglobulin 9-19% 
•  More soluble, as compared to commercial casein used in preliminary experiments  
CROSSLINKING  DEGREE (FOLLOW-UP) 
 
• CL steadied after 10h, but the reaction was left to proceed during 24h 
for maximum crosslinking 
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Fig. 2 – Crosslinking degree of skimmed milk protein micelles 
CL estimated from the 
remaining free amino groups 
by the ninhydrin method  
PARTICLE SIZE AND ZETA POTENTIAL  
• CL promoted formation of larger micelles (≈300nm) vs UCL samples (≈170nm) 
• Increased size distribution, consistent with occurrence of intermolecular CL 
• Negative surface charge (-15 to -22 mV), with zeta potential magnitude, indicative 
of redispersibility 
Table 2 – Particle size and Zeta Potential of different micelle formulations 
FT-IR SPECTRA ANALYSIS 
Fig. 3 – Second derivative amide I, II and III spectra of crosslinked (CL) and uncrosslinked (UCL) micelles 
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CL 
UCL 
CL 
UCL 
CL 
 
• FT-IR bands of paracetamol in micelles predominantly invisible due to 
interference of casein bands 
•  Second derivative spectra of CL micelles with altered stretching frequencies 
and peak shifts in amides regions 
• Differences might be attributed to potential intramolecular crosslinking 
MICELLES PREPARATION AND DRUG ENTRAPMENT 
Samples 
CN:drug 
ratios 
Vitamin A  Paracetamol 
Yield (%) CL degree (%) EE (%) Yield (%) CL degree (%) EE (%) 
F0 0:3 82.91 70.04  0.00 87.07 83.94  0.00 
F1 0.09:3 84.25 49.45  1.55 84.93 85.65 3.65 
F2 0.18:3 89.16 53.47  1.56 90.00 79.60 5.45 
F3 0.51:3 94.02 79.72  1.94 91.73 81.84 12.07 
F4 0.63:3 89.78 72.64  1.98 87.33 87.80 15.90 
F5 1:3 93.15 65.25  1.96 87.07 77.83 31.39 
Table 3 – Yield, Crosslinking Degree and Encapsulation Efficiency of skimmed milk protein micelles  
• Micelles unable to entrap vitamin A (EE up to 2%) 
• Paracetamol: EE increased with amount of drug (up to 31%, for 1:3 protein:drug ratio) 
DRUG RELEASE STUDY 
 
• Release of paracetamol was retarded upon encapsulation, particularly in 
CL micelles  
Fig. 4 – Paracetamol release (%) from protein micelles 
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METHODOLOGY 
PRODUCTION OF CASEIN MICELLES 
Fresh skimmed milk was purchased from Mimosa (Portugal) and all reagents were of analytical grade (> 99% purity). Milk proteins (mainly casein; see 
results) were extracted from fresh milk, using a combination of pH (4.1-4.3) and heat treatment (55C), vacuum filtered and dried (40C), until constant 
weight. Proteins extracted were identified and quantified by Coomassie blue stained SDS-PAGE densitometry. Protein (75mg/ml) dispersions in PBS (pH 
7.4), containing 0.5% (w/v) lecithin and 4% (v/v) Tween 80, were produced under magnetic stirring (100 rpm). Drugs (paracetamol or vitamin A) were 
then added in increasing amounts and micelle formation promoted by pH drop (4.1-4.3) with lactic acid; drug-loaded micelles were filtered, washed and 
freeze-dried. Crosslinking was carried out, using 0.1M of EDAC in a water-acetone (2:8) solution (24h, 5ºC, 300 rpm) and the crosslinking degree 
estimated from the remaining free amino groups by the ninhydrin method. Crosslinked (CL) micelles were air-dried until constant weight.  
CHARACTERIZATION OF CASEIN MICELLES 
Micelles were characterized for particle size, zeta potential and FTIR spectra (4000–400 cm-1, resolution 4cm-1, 30 scans). Drugs were quantified by 
UV/vis spectrometry (325nm - vitamin A; 243nm - paracetamol) and the encapsulation efficiency (EE;%) determined. The release of paracetamol from 
uncrosslinked (UCL) and CL micelles was assessed from samples taken at time intervals, upon dialysis (PBS, pH 7.4, 37ºC, 100 rpm) of paracetamol from a 
10 kDa cut-off membrane. Release studies in the presence of proteolytic enzymes were also conducted using trypsin (0.3%; w/v). All measurements were 
made in triplicate. 
• Yield: 83-94% for 
vitamin A and 85-92% 
for paracetamol; 
Crosslinking degree: 
54-80% and 78-88% 
